Genitourinary Cancers

• Renal Cell Carcinoma: ESMO Clinical Practice Guidelines
• ESMO E-Learning: Present and Emerging Treatment Options in HER2/neu Overexpressing Metastatic Breast Cancer
• Participant Clinical Case Discussion: Metastatic Castration Resistant Prostate Cancer with Complete Response After 6 Cycles of Immunotherapy
• Advanced Urinary Cancer (Renal and Bladder)
• ESMO Preceptorship on Prostate Cancer Singapore November 2018
• How to treat men with advanced castration resistant prostate cancer with AR directed therapy?
• SURTIME Indicates Role For Sunitinib Before Cytoreductive Nephrectomy In mRCC Patients
• Prostate cancer vaccines
• Biomarkers for immune therapy in urology cancer: Fact or fiction
• Novel immune combinations for genitourinary cancers
• Ligand-inducible, prostate stem cell antigen (PSCA)-directed GoCAR-T™ cells in advanced solid tumors: Preliminary results from a dose escalation study
• Proffered Paper session II - Invited Discussant 31O, 32O and 68O
• ESMO Preceptorship on Metastatic Bladder and Kidney Cancer Zurich November 2018
• Castration-resistant prostate cancer: Case presentation: Indications for SABR, treatment planning and delivery techniques
• Castration-resistant prostate cancer: Is there a need for combined medical treatment?
• Oligometastatic prostate cancer - Management options: Initial neo-adjuvant systemic treatment
• Oligometastatic prostate cancer - Management options: The radiation oncologist point of view
• Utility of Gallium-68 PSMA PET/CT Scan for Staging and Treatment of Prostate Cancer in Contemporary Era: Study from Tertiary Care Cancer Centre in...
• Prognostic and predictive clinical factors for progression to castration refractory prostate cancer in patients with hormone sensitive prostate can...
• The gap of frailty value from a community-dwelling population predict oncological outcomes in patients with urological cancers
• Comparison between robot-assisted radical prostatectomy and minimum incision endoscopic radical prostatectomy for high-risk prostate cancer followi...
• The impact of different treatment modalities on toxicity and quality of life for prostate cancer - a real-world study based on WeChat in China
• HoxB13 expression in prostate cancer: clinicopathologic characteristics and role as potential diagnostic marker
• Stereotactic body radiotherapy (SBRT) versus conventional fractionated intensity-modulated radiotherapy (CF-IMRT) for Asian patients with early-sta...
• The linear-quadratic (LQ) model is inappropriate for high doses per fraction owing to _/_ ratio is not a constant: evidence deduced from radiothera...

• « Previous
• 1
• 2
• ...
• 81
• Next »